Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB
Clinical trial NCT03069534 · UNKNOWN
Trial details
- NCT number
- NCT03069534
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2019-06-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.